Dr. Jeffrey Scott Ketchersid, MD

Dr. Ketchersid practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Ketchersid's NPI, 1730522871, was assigned on April 8, 2013. Dr. Ketchersid graduated from Washington University School of Medicine in 2013. Dr. Ketchersid holds California license A136374.

Dr. Ketchersid's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Ketchersid's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Ketchersid is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ketchersid practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ketchersid's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ketchersid is licensed in California.

CMS data shows 1,112 Medicare services from Dr. Ketchersid across 7 procedure codes in 2024, for 411 Medicare patients. Medicare paid $124,845 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 411 Medicare patients who saw Dr. Ketchersid in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ketchersid's median patient age at 65, with 48% women.

In 2024, Dr. Ketchersid wrote 169 Medicare Part D claims for 96 patients. 90% of them were for generic drugs. CMS names the drug for 31 of them, across 1 drug with 11 or more claims each, at $96 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ketchersid for performance year 2024, reported as part of a group. Dr. Ketchersid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Ketchersid, published from 2013 to 2020. Dr. Ketchersid's most frequent co-authors are Niaz Banaei, Ryan Patrick Calfee, MD and Shanthi Kappagoda, MD.

CMS Open Payments shows 1 general payment to Dr. Ketchersid from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $22.

Dr. Ketchersid graduated from Washington University School of Medicine in 2013.